Wednesday, Oct 24 2018 | Time 02:09 Hrs(IST)
image
  • Defending Champs India held to a goalless draw by Malaysia
  • MIDC official, aide booked for demanding bribe
  • Rafale jet deal biggest scam in Indian history: Congress
  • Putin invites Trump, via US security adviser, to meet in Paris
Science Technology Share

Dengvaxia, a live recombinant tetravalent dengue vaccine developed by Sanofi Pasteur

Dengvaxia,  a live recombinant tetravalent dengue vaccine developed by Sanofi Pasteur

Kolkata, Dec 5 (UNI) There continues to be a strong public health need for effective preventive interventions against dengue, a disease caused by four viruses, termed serotypes 1-4.

One dengue vaccine has been licensed, Dengvaxia (also referred to as CYD-TDV), developed by Sanofi Pasteur. Dengvaxia is a live recombinant tetravalent dengue vaccine developed by Sanofi Pasteur, given as a 3-dose series on a 0/6/12 month schedule.

Dengvaxia is the first dengue vaccine to be licensed and has now been approved by 19 regulatory authorities for use in endemic areas in persons typically ranging from 9-45 (in some countries 9-60) years of age.

It has been introduced in two subnational programs in the Philippines and Brazil targeting about one million individuals. It is otherwise available on the private market in countries where there is a marketing authorization.

Dengvaxia has been evaluated in two Phase 3 clinical trials (CYD14 trial in five countries in Asia and CYD15 trial in five countries in Latin America). Together, these trials included over 30,000 participants aged 2 to 16 years.

Vaccine efficacy against confirmed dengue pooled across both trials was 59.2 per cent in the year following the primary series, and 79.1 per cent against severe dengue. Efficacy varied by serotype, by age at vaccination and serostatus at baseline (i.e., previous exposure to dengue prior to vaccination).

While efficacy was reported against hospitalized and severe dengue in Years 1 and 2 post-dose 1, an excess of cases of hospitalized and severe dengue cases in those receiving Dengvaxia was seen in Year 3 in some subgroups, although it is based on relatively small numbers of cases. Whether the increased risk was due to age or serostatus at baseline, which is highly correlated with age, could not be fully clarified with the available data at the time.

For subjects aged 9 and above, in the first 25 months of the phase 3 trials, there was a reduction in severe dengue by 93 per cent and a reduction in hospitalizations by 81 per

cent.

MORE UNI BM SJC

More News
United Nations agencies call for ban on virginity testing

United Nations agencies call for ban on virginity testing

18 Oct 2018 | 2:18 PM

Kolkata, Oct 18 (UNI) Virginity testing a gynecological examination conducted under the belief that it determines whether a woman or girl has had vaginal intercourse must end, says UN Human Rights, UN Women and the World Health Organization (WHO).

 Sharesee more..

Reducing free sugars intake in children to reduce risk of noncommunicable diseases

18 Oct 2018 | 12:32 PM

Kolkata, Oct 18 (UNI) Noncommunicable diseases (NCDs) are the world’s leading cause
of death: they were responsible for an estimated 39.

 Sharesee more..

Reducing free sugars intake in children to reduce risk of noncommunicable diseases

18 Oct 2018 | 12:31 PM

Kolkata, Oct 18 (UNI) Noncommunicable diseases (NCDs) are the world’s leading cause of death: they were responsible for an estimated 39.

 Sharesee more..
Ray of hope for same-sex couples: Asexual reproduction possible among mammals!

Ray of hope for same-sex couples: Asexual reproduction possible among mammals!

14 Oct 2018 | 6:58 PM

Beijing, Oct 14 (UNI) Good news for the LGBTQ+ community, as Chinese scientists have achieved success in reproducing healthy offspring from two female mammals.

 Sharesee more..
Eclipse affects bees also, makes them go on silent mode, stop flying

Eclipse affects bees also, makes them go on silent mode, stop flying

13 Oct 2018 | 6:48 PM

Washington, Oct 13 (UNI) Researchers at the University of Missouri have come up with an interesting discovery, which says that during a total eclipse, bees also take a break from their daily routines and stop flying.

 Sharesee more..
image